Polysulfated Glycosaminoglycan

Products Description

Polysulfated Glycosaminoglycan (PSGAG) is a naturally occurring polysaccharide extracted from animal cartilage or synthesized under controlled conditions to ensure high purity and consistency. These compounds belong to the glycosaminoglycan family, known for their structural role in connective tissue and their important function in joint health. PSGAG works by interacting with the extracellular matrix and supporting tissue integrity.

Polysulfated Glycosaminoglycan is supplied as a high-purity, water-soluble powder, suitable for pharmaceutical formulations and veterinary applications. Its stability under normal storage conditions and ease of incorporation into liquid or solid dosage forms make it suitable for research, product development, and clinical applications. For international B2B buyers, PSGAG represents a traceable, reliable, and regulatory-compliant raw material with consistent quality and flexible applications in the veterinary and pharmaceutical sectors targeting joint and connective tissue health.

Supports Joint Integrity
Polysulfated Glycosaminoglycan helps maintain the structural framework of connective tissue. By interacting with the extracellular matrix, it helps support cartilage and joint function.

Reduces Inflammation
Studies have shown that PSGAG can help reduce inflammatory responses in joints, potentially improving mobility and comfort in affected animals.

Approved for Veterinary Use
PSGAG is approved by the US FDA for use in horses and dogs to treat traumatic and non-infectious joint abnormalities, arthritis, stiffness, and lameness.

Potential Cross-Species Benefits
Literature reports suggest that PSGAG may also be beneficial for joint health in other animals, including cats and poultry, highlighting its versatility in veterinary medicine.

Compatibility and Safety
Polysulfated glycosaminoglycan is water-soluble and compatible with injectable formulations. Its safety profile and regulatory approvals make it suitable for controlled veterinary and pharmaceutical settings.

Supports Research and Product Development
PSGAG provides a stable, traceable raw material for preclinical and clinical research, enabling pharmaceutical and veterinary manufacturers to develop reliable joint health products.
 

Veterinary Medicine
Polysulfated Glycosaminoglycan is commonly used in injectable formulations for horses and dogs to treat joint stiffness, lameness, and arthritis. Research and Development
It serves as a reliable raw material for preclinical and clinical studies on joint health, inflammation, and connective tissue support.

Cross-Species Veterinary Use
Polysulfated Glycosaminoglycan can also be used in experimental or specialized veterinary products for cats, poultry, and other animals to explore its benefits for joints.

Pharmaceutical Formulations
Its good solubility and stability allow for its incorporation into liquid or solid dosage forms, supporting its diverse applications in animal health and pharmaceutical research.